Email testing & diagnostics
Check SMTP/IMAP connectivity, DKIM/SPF/DMARC, and bounce reasons before sending a real campaign.
Before running a live sequence, verify your mailbox can actually
send + receive. FlowMaticX ships built-in diagnostics so you don't
need a separate tool.
- Open Deliverability → Mailboxes.
- Click the Test button next to the mailbox.
- The dialog will report:
- SMTP send — can we open a TLS connection and hand off a test message?
- IMAP fetch — can we read the sent folder and confirm delivery?
- Authentication — does the provider accept the credentials?
Typical failures and fixes:
- "Connection timeout" — a firewall is blocking the port. For SMTP,
open 587 (STARTTLS) or 465 (SSL). For IMAP, open 993.
- "Authentication failed" — regenerate the app password on the
provider's side. Gmail requires a real App Password, not your
login password.
- "Relay denied" — your provider requires the
Fromheader to
match the authenticated username. Don't mask the sender.
Open Deliverability → DNS check, paste your sending domain, and
review the three records. Green means your authentication passes;
red means mailbox providers will route you to spam.
If any record is missing:
- Copy the suggested DNS value from the check.
- Add it as a TXT record at your DNS provider.
- Wait 5–30 min for propagation, then re-run the check.
- Create a sequence with your real copy.
- Enroll just yourself (or a friendly internal address).
- Watch the inbox — does the message land in Primary, Promotions,
or Spam?
- If it lands in Spam, pause before sending to real leads and
check your DKIM/SPF first.
Every bounce is logged to Deliverability → Bounce log. Common
categories:
- hard bounce (550) — address doesn't exist. FlowMaticX auto-
suppresses the address so you don't burn it again.
- soft bounce (4xx) — temporary (mailbox full, greylisting).
Retry tomorrow.
- spam complaint (FBL) — recipient clicked "Report spam". We
auto-suppress globally.
If you see >2% bounces, pause and rebuild your list. Apollo-verified
leads typically bounce under 1%.